$5.47
0.09[1.67%]
At close: Apr 25
$5.47
0[0.00%]
After Hours: 6:35PM EDT
Lantern Pharma reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Lantern Pharma using advanced sorting and filters.
Date | time | ticker | Quarter | Prior EPS | Est EPS | Actual EPS | EPS Surprise | Prior Rev | Est Rev | Actual Rev | Rev Surprise | Get Alert |
---|---|---|---|---|---|---|---|---|---|---|---|---|
05/07/2024 | PM | LTRN | Q1 | — | — | — | — | — | — | — | — | Get Alert |
03/18/2024 | PM | LTRN | Q4 | -$0.31 | -$0.40 | -$0.39 | 2.50% | $0.00 | — | $0.00 | — | Get Alert |
11/08/2023 | PM | LTRN | Q3 | -$0.21 | -$0.45 | -$0.29 | 35.56% | $0.00 | — | $0.00 | — | Get Alert |
08/09/2023 | PM | LTRN | Q2 | -$0.41 | -$0.43 | -$0.44 | -2.33% | $0.00 | — | $0.00 | — | Get Alert |
05/09/2023 | PM | LTRN | Q1 | -$0.38 | -$0.48 | — | — | $0.00 | — | — | — | Get Alert |
03/20/2023 | PM | LTRN | Q4 | -$0.31 | -$0.47 | -$0.31 | 34.04% | $0.00 | — | $0.00 | — | Get Alert |
11/07/2022 | PM | LTRN | Q3 | -$0.36 | -$0.54 | -$0.21 | 61.11% | $0.00 | — | $0.00 | — | Get Alert |
08/08/2022 | PM | LTRN | Q2 | -$0.21 | -$0.52 | -$0.41 | 21.15% | $0.00 | — | $0.00 | — | Get Alert |
05/03/2022 | PM | LTRN | Q1 | -$0.24 | -$0.29 | -$0.38 | -31.03% | $0.00 | — | $0.00 | — | Get Alert |
03/10/2022 | PM | LTRN | Q4 | -$0.47 | -$0.40 | -$0.31 | 22.50% | $0.00 | — | $0.00 | — | Get Alert |
11/01/2021 | PM | LTRN | Q3 | -$0.27 | -$0.27 | -$0.36 | -33.33% | $0.00 | — | $0.00 | — | Get Alert |
07/29/2021 | PM | LTRN | Q2 | -$0.31 | -$0.26 | -$0.21 | 19.23% | $0.00 | — | $0.00 | — | Get Alert |
05/03/2021 | PM | LTRN | Q1 | — | -$0.27 | -$0.24 | 11.11% | — | — | $0.00 | — | Get Alert |
03/10/2021 | PM | LTRN | Q4 | — | -$0.45 | -$0.47 | -4.44% | — | — | $0.00 | — | Get Alert |
10/29/2020 | PM | LTRN | Q3 | — | -$0.33 | -$0.27 | 18.18% | — | — | $0.00 | — | Get Alert |
07/30/2020 | AM | LTRN | Q2 | — | — | -$0.31 | — | — | — | $0.00 | — | Get Alert |
Lantern Pharma (LTRN) is scheduled to report earnings on May 7, 2024. The last reported earnings were for reported on March 18, 2024 for Q4.
The Actual EPS was $-0.39, which beat the estimate of $-0.40.
The Actual Revenue was $0K, which hit the estimate of $0K.
Browse earnings estimates, EPS, and revenue on all stocks.